$CLFD
Clearfield, Inc.

2024 Q1 Form 10-Q Financial Statement

#000117184324000584 Filed on February 05, 2024

View on sec.gov

Income Statement

Concept 2024 Q1 2023 Q4 2022 Q4
Revenue $36.91M $34.23M $85.94M
YoY Change -48.6% -60.17% 68.15%
Cost Of Revenue $34.08M $29.53M $55.29M
YoY Change -29.37% -46.59% 96.51%
Gross Profit $2.832M $4.697M $30.65M
YoY Change -87.98% -84.67% 33.42%
Gross Profit Margin 7.67% 13.72% 35.66%
Selling, General & Admin $12.57M $12.86M $12.76M
YoY Change 9.25% 0.78% 28.58%
% of Gross Profit 443.96% 273.77% 41.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.877M $1.695M $1.353M
YoY Change 28.74% 25.28% 111.74%
% of Gross Profit 66.28% 36.09% 4.41%
Operating Expenses $12.57M $12.86M $12.76M
YoY Change 9.25% 0.78% 28.58%
Operating Profit -$9.741M -$8.162M $17.89M
YoY Change -180.8% -145.62% 37.1%
Interest Expense $1.747M $126.0K $243.0K
YoY Change 1459.82% -48.15% 102.5%
% of Operating Profit 1.36%
Other Income/Expense, Net $1.000K
YoY Change
Pretax Income -$7.994M -$6.219M $17.95M
YoY Change -159.93% -134.65% 36.3%
Income Tax -$2.083M -$951.0K $3.695M
% Of Pretax Income 20.58%
Net Earnings -$5.911M -$5.268M $14.26M
YoY Change -157.03% -136.96% 37.21%
Net Earnings / Revenue -16.01% -15.39% 16.59%
Basic Earnings Per Share -$0.40 -$0.35 $1.01
Diluted Earnings Per Share -$0.40 -$0.35 $1.00
COMMON SHARES
Basic Shares Outstanding 14.71M 15.25M 13.82M
Diluted Shares Outstanding 14.63M 15.21M 14.28M

Balance Sheet

Concept 2024 Q1 2023 Q4 2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $142.9M $162.8M $147.9M
YoY Change -9.01% 10.14% 541.3%
Cash & Equivalents $15.82M $34.48M $30.31M
Short-Term Investments $127.1M $128.4M $117.5M
Other Short-Term Assets $8.641M $1.806M $1.450M
YoY Change 136.42% 24.55% 33.64%
Inventory $83.99M $94.61M $89.71M
Prepaid Expenses
Receivables $21.90M $17.36M $55.14M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $257.4M $276.6M $294.1M
YoY Change -14.46% -5.96% 249.99%
LONG-TERM ASSETS
Property, Plant & Equipment $34.83M $22.87M $19.73M
YoY Change 65.16% 15.91% 200.12%
Goodwill $6.568M $6.615M $6.545M
YoY Change -0.29% 1.07% 38.99%
Intangibles $6.219M $5.982M $6.488M
YoY Change -3.72% -7.8% 42.69%
Long-Term Investments $6.523M $6.505M $10.29M
YoY Change -23.5% -36.8% -70.75%
Other Assets $3.833M $988.0K $868.0K
YoY Change 326.36% 13.82% 51.75%
Total Long-Term Assets $57.97M $59.01M $57.65M
YoY Change 2.69% 2.36% 7.32%
TOTAL ASSETS
Total Short-Term Assets $257.4M $276.6M $294.1M
Total Long-Term Assets $57.97M $59.01M $57.65M
Total Assets $315.4M $335.6M $351.8M
YoY Change -11.75% -4.6% 155.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $5.914M $7.368M $18.37M
YoY Change -64.54% -59.88% 48.52%
Accrued Expenses $12.37M $2.750M $12.44M
YoY Change 144.99% -77.89% 155.25%
Deferred Revenue
YoY Change
Short-Term Debt $5.931M $3.532M $0.00
YoY Change -30.02%
Long-Term Debt Due $2.159M $2.214M
YoY Change
Total Short-Term Liabilities $26.38M $24.95M $45.32M
YoY Change -34.14% -44.94% 105.29%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $2.132M
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $9.098M $9.973M $9.706M
YoY Change 1.73% 2.75% 699.51%
Total Long-Term Liabilities $9.098M $9.973M $11.84M
YoY Change -18.21% -15.75% 875.12%
TOTAL LIABILITIES
Total Short-Term Liabilities $26.38M $24.95M $45.32M
Total Long-Term Liabilities $9.098M $9.973M $11.84M
Total Liabilities $36.20M $35.53M $57.92M
YoY Change -30.39% -38.65% 148.66%
SHAREHOLDERS EQUITY
Retained Earnings $116.2M $122.1M $109.1M
YoY Change -2.67% 12.0% 95.34%
Common Stock $144.0K $149.0K $152.0K
YoY Change -5.88% -1.97% 10.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $279.2M $300.1M $293.9M
YoY Change
Total Liabilities & Shareholders Equity $315.4M $335.6M $351.8M
YoY Change -11.75% -4.6% 155.36%

Cashflow Statement

Concept 2024 Q1 2023 Q4 2022 Q4
OPERATING ACTIVITIES
Net Income -$5.911M -$5.268M $14.26M
YoY Change -157.03% -136.96% 37.21%
Depreciation, Depletion And Amortization $1.877M $1.695M $1.353M
YoY Change 28.74% 25.28% 111.74%
Cash From Operating Activities -$3.230M $7.827M $1.103M
YoY Change -135.74% 609.61% -3344.12%
INVESTING ACTIVITIES
Capital Expenditures $1.977M $2.352M $1.984M
YoY Change -23.34% 18.55% -196.73%
Acquisitions
YoY Change
Other Investing Activities $2.225M $3.320M -$98.88M
YoY Change -97.79% -103.36% -5809.06%
Cash From Investing Activities $248.0K $908.0K -$101.1M
YoY Change -99.75% -100.9% 31590.91%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net $0.00 $16.70M
YoY Change -100.0%
Cash From Financing Activities -15.64M -$12.17M $113.5M
YoY Change 12025.58% -110.72% -62817.68%
NET CHANGE
Cash From Operating Activities -3.230M $7.827M $1.103M
Cash From Investing Activities 248.0K $908.0K -$101.1M
Cash From Financing Activities -15.64M -$12.17M $113.5M
Net Change In Cash -18.62M -$3.343M $13.66M
YoY Change -117.43% -124.47% -2658.61%
FREE CASH FLOW
Cash From Operating Activities -$3.230M $7.827M $1.103M
Capital Expenditures $1.977M $2.352M $1.984M
Free Cash Flow -$5.207M $5.475M -$881.0K
YoY Change -180.62% -721.45% -143.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
9973000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
10629000 usd
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
607000 usd
CY2023Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
721000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
35534000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
40354000 usd
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 usd
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
149000 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
153000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
188218000 usd
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
476000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-544000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
122148000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
127336000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
300095000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
315163000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
335629000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
355517000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
660000 usd
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14939671
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34230000 usd
CY2023Q4 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2023Q4 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q4 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
CY2023Q4 dei Amendment Flag
AmendmentFlag
false
CY2023Q4 dei Entity Central Index Key
EntityCentralIndexKey
0000796505
CY2023Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 usd
CY2023Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023Q4 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 pure
CY2023 us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0 usd
CY2023 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P5Y
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14939671
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
177322000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85942000 usd
CY2023Q4 us-gaap Cost Of Revenue
CostOfRevenue
29533000 usd
CY2022Q4 us-gaap Cost Of Revenue
CostOfRevenue
55293000 usd
CY2023Q4 us-gaap Gross Profit
GrossProfit
4697000 usd
CY2022Q4 us-gaap Gross Profit
GrossProfit
30649000 usd
CY2023Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12859000 usd
CY2022Q4 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
12759000 usd
CY2023Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
-8162000 usd
CY2022Q4 us-gaap Operating Income Loss
OperatingIncomeLoss
17890000 usd
CY2023Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
2069000 usd
CY2022Q4 us-gaap Investment Income Interest
InvestmentIncomeInterest
303000 usd
CY2023Q4 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
126000 usd
CY2022Q4 us-gaap Investment Income Investment Expense
InvestmentIncomeInvestmentExpense
243000 usd
CY2023Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-6219000 usd
CY2022Q4 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
17950000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-951000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3695000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5268000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14255000 usd
CY2023Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.35
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
CY2023Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.35
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15212945
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14165550
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15212945
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14284847
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5268000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14255000 usd
CY2023Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
291000 usd
CY2022Q4 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
141000 usd
CY2023Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
729000 usd
CY2022Q4 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
1024000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1020000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
1165000 usd
CY2023Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4248000 usd
CY2022Q4 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
15420000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
315163000 usd
CY2023Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1271000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
250000 usd
CY2023Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
0 usd
CY2023Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
236000 usd
CY2023Q4 us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
12185000 usd
CY2023Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
1020000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5268000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
300095000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
147582000 usd
CY2022Q4 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
660000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
299000 usd
CY2022Q4 us-gaap Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures
954000 usd
CY2022Q4 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
954000 usd
CY2022Q4 clfd Stock Issued During Period Value Withholding Related To Stock Options Exercised
StockIssuedDuringPeriodValueWithholdingRelatedToStockOptionsExercised
342000 usd
CY2022Q4 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
130262000 usd
CY2022Q4 us-gaap Other Comprehensive Income Loss Before Tax
OtherComprehensiveIncomeLossBeforeTax
1165000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14255000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
293881000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5268000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14255000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1695000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1353000 usd
CY2023Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
44000 usd
CY2022Q4 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-0 usd
CY2023Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
1160000 usd
CY2022Q4 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
218000 usd
CY2023Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-320000 usd
CY2022Q4 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-80000 usd
CY2023Q4 us-gaap Share Based Compensation
ShareBasedCompensation
1271000 usd
CY2022Q4 us-gaap Share Based Compensation
ShareBasedCompensation
660000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11750000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
549000 usd
CY2023Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-4169000 usd
CY2022Q4 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6505000 usd
CY2023Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-815000 usd
CY2022Q4 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
176000 usd
CY2023Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-5081000 usd
CY2022Q4 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-7637000 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
7827000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1103000 usd
CY2023Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2412000 usd
CY2022Q4 us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
2213000 usd
CY2023Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
47748000 usd
CY2022Q4 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
98881000 usd
CY2023Q4 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
51068000 usd
CY2022Q4 us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
908000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-101094000 usd
CY2023Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
-0 usd
CY2022Q4 us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
16700000 usd
CY2023Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
250000 usd
CY2022Q4 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
299000 usd
CY2023Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
236000 usd
CY2022Q4 us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
954000 usd
CY2023Q4 clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
-0 usd
CY2022Q4 clfd Payments For Proceeds From Tax Withholding Stock Options Exercised
PaymentsForProceedsFromTaxWithholdingStockOptionsExercised
342000 usd
CY2023Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
0 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans
954000 usd
CY2023Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2022Q4 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
130262000 usd
CY2023Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
12185000 usd
CY2022Q4 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
-0 usd
CY2023Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-12171000 usd
CY2022Q4 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
113519000 usd
CY2023Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
93000 usd
CY2022Q4 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
135000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3343000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
13663000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
37827000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
16650000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
34484000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
30313000 usd
CY2023Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
61000 usd
CY2022Q4 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
0 usd
CY2023Q4 us-gaap Interest Paid Net
InterestPaidNet
86000 usd
CY2022Q4 us-gaap Interest Paid Net
InterestPaidNet
205000 usd
CY2023Q4 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
0 usd
CY2022Q4 clfd Issuance Of Common Stock Funded Through Shares Sold To Company
IssuanceOfCommonStockFundedThroughSharesSoldToCompany
431000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5268000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14255000 usd
CY2023Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
15212945
CY2022Q4 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
14165550
CY2023Q4 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
0
CY2022Q4 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
119297
CY2023Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
15212945
CY2022Q4 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14284847
CY2022Q4 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.01
CY2022Q4 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1
CY2023Q4 us-gaap Cash And Due From Banks
CashAndDueFromBanks
9156000 usd
CY2023Q3 us-gaap Cash And Due From Banks
CashAndDueFromBanks
11360000 usd
CY2023Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
25328000 usd
CY2023Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
26467000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
34484000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
37827000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
38452000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
50000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
10664000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
509000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months
113153000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position Less Than12 Months Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss
131000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger
23476000 usd
CY2023Q3 us-gaap Debt Securities Available For Sale Continuous Unrealized Loss Position12 Months Or Longer Accumulated Loss
DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss
755000 usd
CY2023Q4 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
25 pure
CY2023Q3 us-gaap Debt Securities Available For Sale Unrealized Loss Position Number Of Positions
DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions
42 pure
CY2023Q4 clfd Cash Equivalents Fair Value Disclosure
CashEquivalentsFairValueDisclosure
25328000 usd
CY2023Q4 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
134857000 usd
CY2023Q3 clfd Cash Equivalents Fair Value Disclosure
CashEquivalentsFairValueDisclosure
26467000 usd
CY2023Q3 us-gaap Available For Sale Securities Debt Securities
AvailableForSaleSecuritiesDebtSecurities
136629000 usd
CY2023Q4 clfd Revenues Percent
RevenuesPercent
1 pure
CY2022Q4 clfd Revenues Percent
RevenuesPercent
1 pure
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
0 usd
CY2023Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
79000 usd
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1271000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
8668000 usd
CY2023Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y10M24D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
111299
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.18
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
15020
CY2022Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
104.36
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.6171 pure
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0455 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P3Y6M
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P3Y
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
254124
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
37.04
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
111299
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
26.18
CY2023Q4 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
-0
CY2023Q4 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
1731
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
41.64
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
363692
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
33.69
CY2023Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P2Y1M20D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
1258000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34230000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85942000 usd
CY2023Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
34230000 usd
CY2023Q4 us-gaap Revenue Not From Contract With Customer Excluding Interest Income
RevenueNotFromContractWithCustomerExcludingInterestIncome
0 usd
CY2023Q4 us-gaap Net Investment Income
NetInvestmentIncome
2069000 usd
CY2023Q4 us-gaap Interest Expense
InterestExpense
126000 usd
CY2023Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1695000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
68755000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
73657000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
2752000 usd
CY2023Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1462000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
33033000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
29696000 usd
CY2023Q4 us-gaap Inventory Gross
InventoryGross
104540000 usd
CY2023Q3 us-gaap Inventory Gross
InventoryGross
104815000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
9927000 usd
CY2023Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
6760000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
94613000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
98055000 usd
CY2023Q4 clfd Number Of Patents Granted
NumberOfPatentsGranted
48 pure
CY2023Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1271000 usd
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-951000 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-5268000 usd
CY2023Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2352000 usd
CY2022Q4 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
85942000 usd
CY2022Q4 us-gaap Revenue Not From Contract With Customer Excluding Interest Income
RevenueNotFromContractWithCustomerExcludingInterestIncome
0 usd
CY2022Q4 us-gaap Net Investment Income
NetInvestmentIncome
303000 usd
CY2022Q4 us-gaap Interest Expense
InterestExpense
243000 usd
CY2022Q4 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
1353000 usd
CY2022Q4 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
660000 usd
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3695000 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
14255000 usd
CY2022Q4 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1984000 usd
CY2023Q4 us-gaap Assets
Assets
335629000 usd
CY2022Q4 us-gaap Goodwill
Goodwill
6545000 usd
CY2022Q4 us-gaap Assets
Assets
351797000 usd
CY2023Q4 clfd Factoring Liabilities
FactoringLiabilities
3532000 usd
CY2023Q4 clfd Financing Receivables Percentage Of Cash Initially Received
FinancingReceivablesPercentageOfCashInitiallyReceived
0.80 pure
CY2023Q4 clfd Financing Receivable Percentage Of Balance Received When Invoice Is Paid
FinancingReceivablePercentageOfBalanceReceivedWhenInvoiceIsPaid
0.20 pure
CY2023Q4 clfd Financing Receivable Limit
FinancingReceivableLimit
12500000 eur
CY2023Q4 clfd Financing Receivable Limit
FinancingReceivableLimit
13800000 usd
CY2023Q4 clfd Financing Receivable Average Interest Rate During Period
FinancingReceivableAverageInterestRateDuringPeriod
0.0521 pure
CY2023Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-951000 usd
CY2023Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.153 pure
CY2022Q4 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3695000 usd
CY2022Q4 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.206 pure
CY2023Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
1134000 usd
CY2022Q4 us-gaap Operating Lease Expense
OperatingLeaseExpense
1571000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2967000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
3965000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
3261000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1590000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
402000 usd
CY2023Q4 clfd Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
2932000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
15117000 usd
CY2023Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
1334000 usd
CY2023Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
13784000 usd
CY2023Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y11M8D
CY2023Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0379 pure
CY2022Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P3Y9M14D
CY2022Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0322 pure
CY2023Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
1042000 usd
CY2022Q4 us-gaap Operating Lease Payments
OperatingLeasePayments
946000 usd

Files In Submission

Name View Source Status
clfd-20231231_cal.xml Edgar Link unprocessable
0001171843-24-000584-index-headers.html Edgar Link pending
0001171843-24-000584-index.html Edgar Link pending
0001171843-24-000584.txt Edgar Link pending
0001171843-24-000584-xbrl.zip Edgar Link pending
clfd-20231231.xsd Edgar Link pending
clfd20231231_10q.htm Edgar Link pending
ex_619408.htm Edgar Link pending
ex_619409.htm Edgar Link pending
ex_619410.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
clfd-20231231_def.xml Edgar Link unprocessable
clfd-20231231_lab.xml Edgar Link unprocessable
clfd-20231231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
clfd20231231_10q_htm.xml Edgar Link completed
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending